Sec. 499B–1. Long COVID Research Plan
547 words·~2 min read·
/bill/118/s/4964/is/section-499b-1·A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
Not later than 1 year after the date of enactment of the Long COVID Research Moonshot Act , the Director of the Program established under section 499B shall develop and make public a comprehensive research plan for the conduct and support of all Long COVID research activities of the national research institutes and national centers. The Director of the Program shall update such plan annually. The research plan developed under subsection
(a)shall— identify current Long COVID research conducted or supported by the national research institutes and national centers, opportunities and needs for additional research, including among patients who face the highest disease burden and pediatric patients, and priorities for such research; evaluate the progress of Long COVID research against strategic priorities, goals, and objectives, identified in previous versions of the research plan; make recommendations for the coordination of such research conducted or supported by the National Institutes of Health and other agencies of the Federal Government; and include goals and objectives of the Program for conducting, supporting, and coordinating Long COVID research. In developing the research plan under subsection (a), the Director of the Program shall— ensure that the plan establishes priorities among Long COVID research that the Program is authorized to carry out; ensure that the plan establishes objectives regarding such research and describes the means for achieving the objectives; ensure that all amounts appropriated for such research under section 499B–6 are expended in accordance with the plan; review the plan not less frequently than annually, and revise the plan as appropriate to prioritize funding and research relative to scientific urgency; ensure that the plan serves as a broad, binding statement of policies regarding Long COVID research of the National Institutes of Health, but does not affect the responsibility of any of the national research institutes or centers with respect to the programs or projects of such institutes and centers; and annually prepare and submit to the Director of NIH for review and transmittal by the Director of NIH to the President and to Congress a budget estimate for carrying out the plan for the upcoming fiscal year. In developing, implementing, reviewing, and prioritizing elements of the research plan under this section, the Director of the Program shall consult, as appropriate with— representatives of other Federal agencies involved in Long COVID research, including the Centers for Disease Control and Prevention, the Agency for Healthcare Research and Quality, and the Administration for Community Living; the Long COVID Research Advisory Board established under section 499B–4; the Office of Long COVID Research and Practice of the Department of Health and Human Services; leading scientific experts on Long COVID; and independent, patient-led organizations or advocacy groups representing patients with Long COVID and other infection-associated chronic conditions with similar phenotypes, and the families of such patients. The Director of the Program shall submit the research plan developed under subsection (a), and updates to such plan, to— the Committee on Health, Education, Labor, and Pensions of the Senate; the Committee on Energy and Commerce of the House of Representatives; the Secretary; the Office of Long COVID Research and Practice of the Department of Health and Human Services; and the Director of NIH, who shall post the plan, and updates to the plan, on the website of the National Institutes of Health.